• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因菌种复合体引起的感染的治疗

Treatment of Infections Due to Species Complex.

作者信息

Lass-Flörl Cornelia

机构信息

Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstraße 41, 6020 Innsbruck, Austria.

出版信息

J Fungi (Basel). 2018 Jul 9;4(3):83. doi: 10.3390/jof4030083.

DOI:10.3390/jof4030083
PMID:29987241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6162764/
Abstract

The species complex is found in a wide variety of habitats, and the spectrum of diseases caused covers allergic bronchopulmonary aspergillosis, bronchitis and/or tracheobronchitis, and invasive and disseminated aspergillosis. Invasive infections are a significant cause of morbidity and mortality mainly in patients with hematological malignancy. The section covers a total of 16 accepted species of which most are amphotericin B resistant. Triazoles are the preferred agents for treatment and prevention of invasive aspergillosis. Poor prognosis in patients with invasive infections seems to be independent of anti- azole-based treatment.

摘要

该菌种复合体存在于多种生境中,其所引发的疾病谱涵盖过敏性支气管肺曲霉病、支气管炎和/或气管支气管炎,以及侵袭性和播散性曲霉病。侵袭性感染主要是血液系统恶性肿瘤患者发病和死亡的重要原因。该部分总共涵盖16个公认的菌种,其中大多数对两性霉素B耐药。三唑类药物是治疗和预防侵袭性曲霉病的首选药物。侵袭性感染患者预后不良似乎与基于抗唑类的治疗无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bab/6162764/c29e396ce736/jof-04-00083-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bab/6162764/cb5898b21b26/jof-04-00083-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bab/6162764/c29e396ce736/jof-04-00083-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bab/6162764/cb5898b21b26/jof-04-00083-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bab/6162764/c29e396ce736/jof-04-00083-g002.jpg

相似文献

1
Treatment of Infections Due to Species Complex.因菌种复合体引起的感染的治疗
J Fungi (Basel). 2018 Jul 9;4(3):83. doi: 10.3390/jof4030083.
2
Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy.土曲霉引起的侵袭性曲霉病:一种新出现的机会性感染,预后不良,与唑类治疗无关。
J Antimicrob Chemother. 2014 Nov;69(11):3148-55. doi: 10.1093/jac/dku241. Epub 2014 Jul 8.
3
Aspergillus terreus Species Complex.土曲霉物种复合体。
Clin Microbiol Rev. 2021 Dec 15;34(4):e0031120. doi: 10.1128/CMR.00311-20. Epub 2021 Jun 30.
4
Species Identification and Antifungal Susceptibility of Aspergillus terreus Species Complex Clinical Isolates from a French Multicenter Study.从法国多中心研究中分离的土曲霉种复合体临床分离株的种鉴定和抗真菌药敏试验。
Antimicrob Agents Chemother. 2018 Apr 26;62(5). doi: 10.1128/AAC.02315-17. Print 2018 May.
5
Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.土曲霉:血液系统恶性肿瘤患者中一种新出现的对两性霉素B耐药的机会性霉菌。
Cancer. 2004 Oct 1;101(7):1594-600. doi: 10.1002/cncr.20554.
6
Molecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing.印度德里土曲霉复合种分离株的分子流行病学及体外抗真菌药敏性:通过扩增片段长度多态性和微卫星分型揭示遗传多样性的证据
PLoS One. 2015 Mar 17;10(3):e0118997. doi: 10.1371/journal.pone.0118997. eCollection 2015.
7
Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei.二氢乳清酸脱氢酶抑制剂奥洛福米对曲霉菌属 Terrei 亚属内所有临床相关种均表现出有前景的活性。
J Antimicrob Chemother. 2018 Nov 1;73(11):3068-3073. doi: 10.1093/jac/dky329.
8
In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex.体外抗真菌活性的两性霉素 B 和 11 个对照剂对土曲霉种复合体。
Mycoses. 2018 Feb;61(2):134-142. doi: 10.1111/myc.12716. Epub 2017 Nov 22.
9
Luliconazole, an alternative antifungal agent against Aspergillus terreus.卢立康唑,一种治疗土曲霉的替代抗真菌药物。
J Mycol Med. 2017 Sep;27(3):351-356. doi: 10.1016/j.mycmed.2017.04.011. Epub 2017 May 5.
10
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.土曲霉感染的流行病学及转归:单中心10年经验
Br J Haematol. 2005 Oct;131(2):201-7. doi: 10.1111/j.1365-2141.2005.05763.x.

引用本文的文献

1
Antifungal effects of andrographolide and its combination with amphotericin B against selected fungal pathogens.穿心莲内酯及其与两性霉素B联合使用对特定真菌病原体的抗真菌作用。
PeerJ. 2025 Jun 16;13:e19544. doi: 10.7717/peerj.19544. eCollection 2025.
2
Pyopneumothorax Caused by Aspergillus terreus and Haemophilus influenzae: A Case Report.土曲霉和流感嗜血杆菌引起的脓气胸:一例报告
Cureus. 2024 Dec 31;16(12):e76683. doi: 10.7759/cureus.76683. eCollection 2024 Dec.
3
Antibody Serosurveillance in Tyrol: A Population-Based, Cross-Sectional Study of a Healthy Population.

本文引用的文献

1
Azole-Resistance in and Related Species: An Emerging Problem or a Rare Phenomenon?曲霉及相关菌种中的唑类耐药性:一个新出现的问题还是罕见现象?
Front Microbiol. 2018 Mar 28;9:516. doi: 10.3389/fmicb.2018.00516. eCollection 2018.
2
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.曲霉病的诊断和治疗:2017 年 ESCMID-ECMM-ERS 指南执行摘要。
Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.
3
Aspergillus terreus: Novel lessons learned on amphotericin B resistance.
蒂罗尔州的抗体血清学监测:一项基于人群的健康人群横断面研究。
J Fungi (Basel). 2023 Oct 12;9(10):1008. doi: 10.3390/jof9101008.
4
Novel Antifungals and Section with Potpourri Susceptibility Profiles to Conventional Antifungals.新型抗真菌药物以及对传统抗真菌药物具有混合药敏谱的部分。
J Fungi (Basel). 2023 Jun 6;9(6):649. doi: 10.3390/jof9060649.
5
Addressing Microbial Resistance Worldwide: Challenges over Controlling Life-Threatening Fungal Infections.应对全球微生物耐药性:控制危及生命的真菌感染面临的挑战。
Pathogens. 2023 Feb 10;12(2):293. doi: 10.3390/pathogens12020293.
6
Lipid-Like Biofilm from a Clinical Brain Isolate of Aspergillus terreus: Quantification, Structural Characterization and Stages of the Formation Cycle.来自土曲霉临床分离株的类脂生物膜:定量、结构特征和形成周期阶段。
Mycopathologia. 2023 Apr;188(1-2):35-49. doi: 10.1007/s11046-022-00692-z. Epub 2022 Dec 14.
7
Terrien, a metabolite made by , has activity against .特利烯,一种由 产生的代谢物,对 具有活性。
PeerJ. 2022 Oct 18;10:e14239. doi: 10.7717/peerj.14239. eCollection 2022.
8
Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and management.造血干细胞移植患者的真菌感染:流行病学、诊断与管理综述
Ther Adv Infect Dis. 2021 Aug 19;8:20499361211039050. doi: 10.1177/20499361211039050. eCollection 2021 Jan-Dec.
9
Fatal invasive pulmonary aspergillosis in an immunocompetent patient with COVID-19 due to : A case study.一名免疫功能正常的COVID-19患者发生致命性侵袭性肺曲霉病:病例报告
Clin Case Rep. 2021 Mar 16;9(4):2414-2418. doi: 10.1002/ccr3.4051. eCollection 2021 Apr.
10
Complete genome sequence of lovastatin producer Aspergillus terreus ATCC 20542 and evaluation of genomic diversity among A. terreus strains.土曲霉 ATCC 20542 洛伐他汀产生菌的全基因组序列和土曲霉菌株间基因组多样性的评估。
Appl Microbiol Biotechnol. 2021 Feb;105(4):1615-1627. doi: 10.1007/s00253-021-11133-0. Epub 2021 Jan 30.
土曲霉:两性霉素B耐药性方面的新认识。
Med Mycol. 2018 Apr 1;56(suppl_1):73-82. doi: 10.1093/mmy/myx119.
4
Impact of Morphological Sectors on Antifungal Susceptibility Testing and Virulence Studies.形态区对抗真菌药物敏感性测试和毒力研究的影响。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.00755-17. Print 2017 Dec.
5
Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment.唑类耐药的曲霉病:流行病学、分子机制与治疗。
J Infect Dis. 2017 Aug 15;216(suppl_3):S436-S444. doi: 10.1093/infdis/jix210.
6
A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study.一项前瞻性的国际土曲霉调查:EFISG、ISHAM 和 ECMM 联合研究。
Clin Microbiol Infect. 2017 Oct;23(10):776.e1-776.e5. doi: 10.1016/j.cmi.2017.04.012. Epub 2017 Apr 13.
7
Geographically predominant genotypes of Aspergillus terreus species complex in Austria: s microsatellite typing study.奥地利土曲霉种复合体中具有地理优势的基因型:微卫星分型研究。
Clin Microbiol Infect. 2016 Mar;22(3):270-6. doi: 10.1016/j.cmi.2015.10.021. Epub 2015 Nov 11.
8
Galleria mellonella as a host model to study Aspergillus terreus virulence and amphotericin B resistance.黄粉虫作为研究土曲霉毒力和两性霉素B耐药性的宿主模型。
Virulence. 2015;6(6):591-8. doi: 10.1080/21505594.2015.1045183. Epub 2015 Jun 24.
9
Amphotericin B Resistance in Aspergillus terreus Is Overpowered by Coapplication of Pro-oxidants.通过共同应用促氧化剂克服土曲霉对两性霉素B的耐药性。
Antioxid Redox Signal. 2015 Dec 20;23(18):1424-38. doi: 10.1089/ars.2014.6220. Epub 2015 Oct 8.
10
Blocking Hsp70 enhances the efficiency of amphotericin B treatment against resistant Aspergillus terreus strains.阻断热休克蛋白70可提高两性霉素B治疗耐药土曲霉菌株的效率。
Antimicrob Agents Chemother. 2015 Jul;59(7):3778-88. doi: 10.1128/AAC.05164-14. Epub 2015 Apr 13.